Matches in SemOpenAlex for { <https://semopenalex.org/work/W2981752613> ?p ?o ?g. }
Showing items 1 to 67 of
67
with 100 items per page.
- W2981752613 endingPage "S1052" @default.
- W2981752613 startingPage "S1052" @default.
- W2981752613 abstract "Due to the rarity and indolent natural history of thymic tumors, the prospective randomized trials have been lacking. Surgery is the primary treatment for localized disease and chemotherapy may be indicated in advanced disease. We performed a retrospective review of all cases over a 15-year period at our institution. We retrospectively evaluated all patients who were diagnosed as thymoma and thymic carcinoma during 2003-2017 at Rajavithi hospital. Clinical characteristics, staging, treatment, and outcomes were collected and analyzed. Thymic epithelial neoplasms were identified in 60 patients: 52.0% male with a median age 56.5 years (range, 22-83 years), 87.0% with Eastern Cooperative Oncology Group performance status of 0 to 1. Paraneoplastic syndromes were presented in 21.7%. The distribution by WHO histologic classification was A, 3.3%; AB, 8.3%; B1, 25.0%; B2, 15.0%; B3, 15.0%; C, 1.7%; and thymoma unclassified, 31.7%. The majorities (55%) of patients were stage 1-3. Of 40 patients who underwent operation, 47.5% underwent R0 resection. Nineteen patients received adjuvant radiation and 5 patients received adjuvant chemotherapy. Palliative chemotherapy and radiation were given in 12 and 7 patients, respectively. The overall response rate to palliative chemotherapy was 10/12 (83.3%) with majority (75.0%) of patients received carboplatin plus paclitaxel. After a median follow-up of 26.8 (1-180) months, 53 (88.3%) patients remain alive. Median overall survival (OS) was 79.6 months with OS rate at 5-year being 73.6%. Ability to received surgical resection was the only significant (p = 0.003) prognostic factor on multivariate analysis. Although surgical resection is the mainstay of treatment, it remains clear that these tumors are chemo-sensitive diseases. Traditional cytotoxic agents remain the standard of care in patients with advanced disease. Multidisciplinary approach should be offered in all patients." @default.
- W2981752613 created "2019-11-01" @default.
- W2981752613 creator A5015511703 @default.
- W2981752613 creator A5025711633 @default.
- W2981752613 creator A5074899566 @default.
- W2981752613 date "2019-10-01" @default.
- W2981752613 modified "2023-09-30" @default.
- W2981752613 title "EP1.15-02 Thymic Epithelial Neoplasm: A 15-Year Experience Treatment in Rajavithi Hospital, Thailand" @default.
- W2981752613 doi "https://doi.org/10.1016/j.jtho.2019.08.2337" @default.
- W2981752613 hasPublicationYear "2019" @default.
- W2981752613 type Work @default.
- W2981752613 sameAs 2981752613 @default.
- W2981752613 citedByCount "0" @default.
- W2981752613 crossrefType "journal-article" @default.
- W2981752613 hasAuthorship W2981752613A5015511703 @default.
- W2981752613 hasAuthorship W2981752613A5025711633 @default.
- W2981752613 hasAuthorship W2981752613A5074899566 @default.
- W2981752613 hasBestOaLocation W29817526131 @default.
- W2981752613 hasConcept C126322002 @default.
- W2981752613 hasConcept C141071460 @default.
- W2981752613 hasConcept C146357865 @default.
- W2981752613 hasConcept C151730666 @default.
- W2981752613 hasConcept C203092338 @default.
- W2981752613 hasConcept C2776349617 @default.
- W2981752613 hasConcept C2776694085 @default.
- W2981752613 hasConcept C2778239845 @default.
- W2981752613 hasConcept C2779159893 @default.
- W2981752613 hasConcept C2781451048 @default.
- W2981752613 hasConcept C509974204 @default.
- W2981752613 hasConcept C535046627 @default.
- W2981752613 hasConcept C71924100 @default.
- W2981752613 hasConcept C86803240 @default.
- W2981752613 hasConceptScore W2981752613C126322002 @default.
- W2981752613 hasConceptScore W2981752613C141071460 @default.
- W2981752613 hasConceptScore W2981752613C146357865 @default.
- W2981752613 hasConceptScore W2981752613C151730666 @default.
- W2981752613 hasConceptScore W2981752613C203092338 @default.
- W2981752613 hasConceptScore W2981752613C2776349617 @default.
- W2981752613 hasConceptScore W2981752613C2776694085 @default.
- W2981752613 hasConceptScore W2981752613C2778239845 @default.
- W2981752613 hasConceptScore W2981752613C2779159893 @default.
- W2981752613 hasConceptScore W2981752613C2781451048 @default.
- W2981752613 hasConceptScore W2981752613C509974204 @default.
- W2981752613 hasConceptScore W2981752613C535046627 @default.
- W2981752613 hasConceptScore W2981752613C71924100 @default.
- W2981752613 hasConceptScore W2981752613C86803240 @default.
- W2981752613 hasIssue "10" @default.
- W2981752613 hasLocation W29817526131 @default.
- W2981752613 hasOpenAccess W2981752613 @default.
- W2981752613 hasPrimaryLocation W29817526131 @default.
- W2981752613 hasRelatedWork W153544057 @default.
- W2981752613 hasRelatedWork W2014718521 @default.
- W2981752613 hasRelatedWork W2089396628 @default.
- W2981752613 hasRelatedWork W2124746034 @default.
- W2981752613 hasRelatedWork W2168071502 @default.
- W2981752613 hasRelatedWork W2460868461 @default.
- W2981752613 hasRelatedWork W2907817720 @default.
- W2981752613 hasRelatedWork W4251656405 @default.
- W2981752613 hasRelatedWork W4313330708 @default.
- W2981752613 hasRelatedWork W2118279254 @default.
- W2981752613 hasVolume "14" @default.
- W2981752613 isParatext "false" @default.
- W2981752613 isRetracted "false" @default.
- W2981752613 magId "2981752613" @default.
- W2981752613 workType "article" @default.